Skip to main content
GeneBioTechCo.,Ltd. logo

GeneBioTechCo.,Ltd. — Investor Relations & Filings

Ticker · 086060 ISIN · KR7086060001 KO Manufacturing
Filings indexed 120 across all filing types
Latest filing 2025-02-24 AGM Information
Country KR South Korea
Listing KO 086060

About GeneBioTechCo.,Ltd.

http://www.gbtkorea.com

GeneBioTechCo.,Ltd., operating as GBTKOREA, is a specialized manufacturer of core components for medical X-ray imaging systems. Established in 2002, the company focuses on the design and production of high-frequency X-ray generators and related electronic systems. It provides comprehensive Original Equipment Manufacturer (OEM) customization services, developing tailored solutions for clients in the global medical equipment industry.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Genebiotech Co., Ltd. It contains the meeting agenda, details on voting procedures, and management information, which are standard components of proxy solicitation materials sent to shareholders to request their attendance and votes for the upcoming AGM. While it includes financial statements, these are provided as part of the 'Management Reference' (경영참고사항) required for the meeting. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2025-02-24 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Jinbiotech. It outlines the date, location, agenda items (financial statement approval, articles of incorporation amendment, director appointment, and remuneration limits), and details regarding the board's resolution. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2025-02-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of holding an upcoming Annual General Meeting (AGM). Since it is a brief regulatory notice regarding meeting preparation rather than the meeting materials themselves or a full report, it falls under the general regulatory filing category.
2024-12-11 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '진바이오텍' (GeneBioTech Co., Ltd) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
[첨부추가]신규시설투자등(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure from a Korean company (Jinbiotech) regarding a 'New Facility Investment' (신규시설투자). It details the investment amount, purpose, and board approval date. Since this is a specific corporate announcement regarding capital expenditure and does not fit into the other specific categories like M&A or share issues, it falls under the general regulatory filing category.
2024-10-08 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of an outside director (윤철복) for the company (주)진바이오텍. This falls under the category of Board/Management Information, specifically regarding changes in the board composition.
2024-08-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.